Lucid Diagnostics Stock Price on November 15, 2024
| LUCD Stock | USD 1.00 0.02 2.04% |
If you're considering investing in Lucid Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lucid Diagnostics stands at 1.00, as last reported on the 29th of November, with the highest price reaching 1.00 and the lowest price hitting 0.95 during the day. Lucid Diagnostics appears to be very risky, given 3 months investment horizon. Lucid Diagnostics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Lucid Diagnostics, which you can use to evaluate the volatility of the firm. Please exercise Lucid Diagnostics' Risk Adjusted Performance of 0.1112, downside deviation of 2.89, and Mean Deviation of 2.16 to check out if our risk estimates are consistent with your expectations.
At present, Lucid Diagnostics' Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 7 M, whereas Total Stockholder Equity is projected to grow to (2.2 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.06, whereas Price To Sales Ratio is forecasted to decline to 23.04. Lucid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lucid |
Sharpe Ratio = 0.1334
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LUCD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Lucid Diagnostics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lucid Diagnostics by adding it to a well-diversified portfolio.
Price Book 2.159 | Enterprise Value Ebitda (0.67) | Price Sales 13.2359 | Shares Float 18.1 M | Wall Street Target Price 3.5417 |
Related Headline
Beyond Air Headline on 15th of November 2024
Roth Capital Has Bullish Estimate for Beyond Air Q3 Earnings by thelincolnianonline.com
Beyond Air, Inc. Stock analysts at Roth Capital raised their Q3 2025 EPS estimates for shares of Beyond Air in a research report issued on Tuesday, November 12th. Roth Capital analyst J. Wittes now expects that the company will post earnings per share of for the quarter, up from
Lucid Diagnostics Valuation on November 15, 2024
It is possible to determine the worth of Lucid Diagnostics on a given historical date. On November 15, 2024 Lucid was worth 1.03 at the beginning of the trading date compared to the closed value of 0.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lucid Diagnostics stock. Still, in general, we apply an absolute valuation method to find Lucid Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lucid Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lucid Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 1.04 | 1.04 | 0.99 | 1.01 | 507,527 | |
11/15/2024 | 1.03 | 1.03 | 0.97 | 0.99 | 428,157 |
| 0.95 | 0.97 | 0.90 | 0.95 | 775,395 |
| Backtest Lucid Diagnostics | | | Lucid Diagnostics History | | | Lucid Diagnostics Valuation | Previous | Next |
Lucid Diagnostics Trading Date Momentum on November 15, 2024
| On November 18 2024 Lucid Diagnostics was traded for 0.95 at the closing time. The top price for the day was 0.97 and the lowest listed price was 0.90 . The trading volume for the day was 775.4 K. The trading history from November 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.04% . The trading delta at closing time against the current closing price is 1.01% . |
Lucid Diagnostics Fundamentals Correlations and Trends
By evaluating Lucid Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lucid Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lucid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lucid Diagnostics Stock history
Lucid Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lucid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lucid Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lucid Diagnostics stock prices may prove useful in developing a viable investing in Lucid Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.8 M | 41.1 M | |
| Net Loss | -50.6 M | -48 M |
Lucid Diagnostics Stock Technical Analysis
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lucid Diagnostics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Lucid Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lucid Diagnostics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns
Lucid Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lucid Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Lucid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lucid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1112 | |||
| Jensen Alpha | 0.3329 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.0867 | |||
| Treynor Ratio | 1.27 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |